Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Cash Flow Reinvestment Rate
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd cash flow reinvestment rate. Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Cash Flow Reinvestment Rate of 1.10x as of December 2023, reinvesting CN¥9.28 Million (capex CN¥4.72 Million plus investments CN¥-4.56 Million) from operating cash flow of CN¥8.45 Million. Explore 600671 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)
Cash flow reinvestment rate of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 1998 to 2025. Historical reinvestment intensity for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd across 17 annual periods. Explore how much does Hangzhou TianMuShan Pharmaceutical Enter reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Cash Flow Reinvestment Rate by Year (1998–2025)
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd cash flow reinvestment rate by year from 1998 to 2025. Year-by-year capital reinvestment analysis for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. For the full cash flow conversion analysis, see Hangzhou TianMuShan Pharmaceutical Enter (600671) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.64x | CN¥31.18 Million | CN¥11.79 Million | CN¥31.18 Million | ▲ +175.8% |
| 2019 | 0.96x | CN¥154.50 Million | CN¥161.13 Million | CN¥94.66 Million | ▼ -30.3% |
| 2018 | 1.38x | CN¥97.30 Million | CN¥70.71 Million | CN¥37.46 Million | ▼ -51.6% |
| 2017 | 2.84x | CN¥69.76 Million | CN¥24.52 Million | CN¥62.25 Million | ▼ -86.0% |
| 2016 | 20.36x | CN¥32.72 Million | CN¥1.61 Million | CN¥25.21 Million | ▼ -56.3% |
| 2014 | 46.59x | CN¥30.46 Million | CN¥653.79K | CN¥30.46 Million | ▲ +4864.1% |
| 2013 | 0.94x | CN¥11.61 Million | CN¥12.37 Million | CN¥11.61 Million | ▼ -75.2% |
| 2009 | 3.79x | CN¥28.74 Million | CN¥7.58 Million | CN¥28.74 Million | ▲ +381.2% |
| 2008 | 0.79x | CN¥16.69 Million | CN¥21.19 Million | CN¥16.69 Million | ▼ -55.3% |
| 2007 | 1.76x | CN¥83.83 Million | CN¥47.53 Million | CN¥83.83 Million | ▲ +602.5% |
| 2006 | 0.25x | CN¥13.90 Million | CN¥55.39 Million | CN¥13.90 Million | ▼ -81.5% |
| 2005 | 1.36x | CN¥11.54 Million | CN¥8.48 Million | CN¥11.54 Million | ▼ -78.1% |
| 2004 | 6.22x | CN¥8.42 Million | CN¥1.35 Million | CN¥8.42 Million | ▲ +657.4% |
| 2002 | 0.82x | CN¥17.90 Million | CN¥21.80 Million | CN¥17.90 Million | ▼ -3.7% |
| 2001 | 0.85x | CN¥8.97 Million | CN¥10.52 Million | CN¥8.97 Million | ▲ +138.9% |
| 1999 | 0.36x | CN¥17.53 Million | CN¥49.09 Million | CN¥17.53 Million | ▼ -95.6% |
| 1998 | 8.11x | CN¥19.10 Million | CN¥2.36 Million | CN¥19.10 Million | — |